
Spectrum Pharmaceuticals SPPI
Spectrum Pharmaceuticals Operativer Cashflow | SPPI
Operativer Cashflow Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -97 M | -119 M | -122 M | -135 M | -62.4 M | -38.9 M | -40.5 M | 6.74 M | -3.63 M | -2.09 M | 72 M | 43.3 M | -22.5 M | -17.6 M | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 72 M | -135 M | -38.5 M |
Operativer Cashflow Vierteljährlich Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.4 M | -25.3 M | -17.9 M | -23.4 M | -30.3 M | -30.3 M | -25 M | -29.6 M | -34.5 M | -33.3 M | -27.9 M | -27 M | -33.3 M | -31.2 M | -27.1 M | -36.3 M | -40.1 M | -12.3 M | -10.8 M | -12.5 M | -26.7 M | -12.9 M | -6.5 M | 673 K | -20.1 M | -3.36 M | -13 M | -17.1 M | -7.08 M | 3.1 M | -9.34 M | 18.3 M | -5.29 M | 11 M | 9.69 M | 15.7 M | -40 M | 7.92 M | -13.4 M | -18.2 M | 21.6 M | 8.1 M | 18.9 M | 18 M | 26.9 M | 11 M | 20 M | 12.3 M | -16.4 M |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 26.9 M | -40.1 M | -10.9 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Zai Lab Limited
ZLAB
|
-151 M | $ 21.01 | -4.16 % | $ 23 B | ||
|
Zentalis Pharmaceuticals
ZNTL
|
-125 M | $ 1.37 | 0.74 % | $ 98.5 M | ||
|
Zoetis
ZTS
|
2.9 B | $ 78.81 | -2.47 % | $ 34.9 B | ||
|
Xenetic Biosciences
XBIO
|
-2.29 M | $ 1.47 | -4.55 % | $ 2.5 M | ||
|
Taysha Gene Therapies
TSHA
|
-93.1 M | $ 3.71 | -1.72 % | $ 1.19 B | ||
|
Vericel Corporation
VCEL
|
51.9 M | $ 57.41 | -1.46 % | $ 2.89 B | ||
|
Vir Biotechnology
VIR
|
-392 M | $ 8.37 | -5.64 % | $ 1.16 B | ||
|
Veracyte
VCYT
|
136 M | $ 25.08 | 0.16 % | $ 1.97 B | ||
|
Viking Therapeutics
VKTX
|
-279 M | $ 24.72 | -4.35 % | $ 2.79 B | ||
|
Vanda Pharmaceuticals
VNDA
|
-109 M | $ 3.44 | -6.27 % | $ 203 M | ||
|
VistaGen Therapeutics
VTGN
|
-66.4 M | $ 0.16 | -12.33 % | $ 6.09 M | ||
|
Voyager Therapeutics
VYGR
|
-132 M | $ 1.52 | -5.9 % | $ 89.2 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-17.6 M | $ 2.74 | -5.03 % | $ 29.2 M | ||
|
Wave Life Sciences Ltd.
WVE
|
-187 M | $ 2.56 | -6.07 % | $ 432 M | ||
|
XBiotech
XBIT
|
-39.9 M | $ 1.75 | 4.17 % | $ 53.4 M | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
-1.62 M | $ 1.37 | -7.43 % | $ 922 M | ||
|
Adial Pharmaceuticals
ADIL
|
-6.49 M | $ 3.15 | -35.42 % | $ 2.11 M | ||
|
ADMA Biologics
ADMA
|
50.4 M | $ 13.18 | -1.2 % | $ 3.14 B | ||
|
Exicure
XCUR
|
-8.56 M | $ 0.96 | -7.24 % | $ 6.05 M | ||
|
Xencor
XNCR
|
-135 M | $ 33.48 | -1.56 % | $ 2.49 B | ||
|
Cortexyme
CRTX
|
-41.4 M | - | -1.05 % | $ 67.1 M | ||
|
Burford Capital Limited
BUR
|
-29 M | $ 3.24 | -5.55 % | $ 710 M | ||
|
Daré Bioscience
DARE
|
-9.89 M | $ 0.41 | -9.93 % | $ 4.58 M | ||
|
Fate Therapeutics
FATE
|
-106 M | $ 0.92 | -9.07 % | $ 109 M | ||
|
Greenwich LifeSciences
GLSI
|
-9.91 M | $ 19.09 | -3.54 % | $ 258 M | ||
|
Halozyme Therapeutics
HALO
|
652 M | $ 91.28 | -1.89 % | $ 10.9 B | ||
|
Hutchison China MediTech Limited
HCM
|
-64.7 M | $ 13.18 | -2.04 % | $ 11.3 B | ||
|
Aptorum Group Limited
APM
|
-1.84 M | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
-23.2 M | $ 0.83 | 3.01 % | $ 86.4 M | ||
|
Kodiak Sciences
KOD
|
-136 M | $ 97.05 | -0.87 % | $ 5.16 B | ||
|
Karyopharm Therapeutics
KPTI
|
-75.4 M | $ 0.02 | -56.5 % | $ 219 | ||
|
FSD Pharma
HUGE
|
-8.24 M | - | 5743.5 % | $ 69.7 M | ||
|
BioAtla
BCAB
|
-5.69 M | $ 1.74 | 0.64 % | $ 102 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
209 M | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
-162 M | $ 28.91 | -8.89 % | $ 1.39 B | ||
|
Catalyst Biosciences
CBIO
|
1.01 M | $ 13.01 | 0.74 % | $ 1.16 B | ||
|
ARCA biopharma
ABIO
|
-88.2 M | - | 1052.0 % | $ 415 M | ||
|
ADiTx Therapeutics
ADTX
|
-25.7 M | - | - | $ 374 |